Acquiring an established OT practice gives you immediate insurance contracts, credentialed therapists, and proven referral pipelines — but building from scratch lets you design the clinical model, payor mix, and culture on your own terms. Here's how to decide which path is right for you.
Occupational therapy is a structurally growing, recession-resistant segment of the $50 billion rehabilitation services market. Whether you're a PE-backed healthcare platform looking to expand your footprint, a clinician-founder seeking to scale, or an individual buyer pursuing a cash-flowing healthcare business, you face the same foundational question: acquire an existing clinic or build a new one? The answer depends heavily on your access to capital, operational experience, risk tolerance, and how quickly you need to generate revenue. Buying an established OT clinic in the $1M–$5M revenue range typically means paying a 3.5x–6x EBITDA multiple, but you inherit credentialed staff, active payor contracts, and physician referral relationships that can take years to replicate. Building a de novo clinic offers greater control and lower upfront cost, but the path to profitability is long, credentialing timelines are punishing, and referral network development requires sustained relationship capital that most new entrants underestimate. This analysis breaks down both paths with specificity to the occupational therapy industry.
Find Occupational Therapy Clinic Businesses to AcquireAcquiring an established occupational therapy clinic gives buyers immediate access to the three assets that matter most in this industry: active insurance contracts with Medicare, Medicaid, and commercial payers; a credentialed, multi-therapist clinical team; and documented referral relationships with physicians, school districts, and hospitals. In a sector where credentialing alone can take 90–180 days per payer and referral trust takes years to build, buying compresses your timeline to cash flow from years to days. For PE-backed platforms and individual buyers alike, acquisition is often the faster path to a defensible, recurring-revenue business in the OT space.
PE-backed rehabilitation platforms seeking to add a credentialed, cash-flowing location; individual buyers with healthcare operations experience who want immediate recurring revenue; and strategic acquirers in physical or occupational therapy consolidation who need an established brand and referral network in a new geography.
Building a de novo occupational therapy clinic from scratch gives you complete control over clinical specialty, payor mix strategy, staffing culture, and market positioning — but the path from lease signing to sustainable profitability is far longer and more capital-intensive than most first-time builders anticipate. The single biggest friction point in de novo OT clinic development is the credentialing and insurance enrollment process, which can take 6–18 months to complete across all major payers. Until those contracts are active, you cannot bill insurance — meaning your revenue is limited to private-pay or cash-based services while your fixed costs accumulate. Building works best when you have a specific clinical niche, an existing patient base, or a referral network already in place before you open your doors.
Licensed occupational therapists with an existing patient base, referral relationships, or specialty clinical expertise who want to build around their own practice; clinician-founders entering a specific underserved niche like pediatric OT or hand therapy in a market with limited competition; and healthcare entrepreneurs with sufficient personal capital to absorb 12–24 months of pre-profitability operating losses.
For most buyers in the lower middle market — particularly those without an existing patient base or deep physician referral relationships — acquiring an established occupational therapy clinic is the stronger path. The structural barriers to building a de novo OT clinic are unusually high compared to other healthcare service businesses: credentialing timelines are long, referral networks are relationship-dependent, and therapist labor competition is intensifying. A well-structured acquisition using SBA 7(a) financing gets you to positive cash flow in weeks rather than years, with a validated payor mix, a credentialed team, and documented referral sources that would cost multiples of their value to recreate organically. Build only if you are an OT clinician with an existing book of relationships and specific clinical differentiation that justifies starting clean — otherwise, buy right, conduct rigorous due diligence on payor mix and key-person risk, and use earnouts and equity rollover to protect against post-close revenue attrition.
Do I have existing relationships with physicians, school districts, or hospital discharge planners who can immediately refer patients to a new clinic — or would I be starting a referral network from zero, facing a 2–3 year ramp to meaningful volume?
Can I financially sustain 12–18 months of operating losses and cash burn during the insurance credentialing and payer enrollment process, or do I need a business generating positive cash flow within 90 days of my first investment?
Is the acquisition target's revenue genuinely transferable — are referral relationships documented, therapists under employment agreements with non-solicitation clauses, and does no single OT generate more than 30–40% of clinical volume?
Do I have a specific clinical niche — pediatric sensory integration, hand therapy, neurorehabilitation — that gives me differentiation and premium reimbursement potential in a market underserved by existing practices?
Does the acquisition target's payor mix, with less than 40% Medicaid exposure and strong commercial insurance penetration, support the 15–25% EBITDA margins I need to justify the purchase price and service any acquisition debt?
Browse Occupational Therapy Clinic Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Established OT clinics generating $1M–$5M in revenue typically trade at 3.5x–6x EBITDA, translating to total acquisition costs ranging from approximately $750K to $3.5M. Higher multiples are justified by diversified payor mix, multi-therapist staff under contract, strong physician referral relationships, and specialty clinical programs like hand therapy or pediatric sensory integration that generate premium reimbursement. SBA 7(a) loans can finance 80–90% of the purchase price, requiring a buyer equity injection of 10–20%.
Credentialing and payer enrollment timelines for a de novo occupational therapy clinic typically run 90–180 days per payer for established insurers like Medicare and major commercial plans, with the full credentialing process across a diversified payor mix often taking 12–18 months. Until credentialing is complete, the clinic cannot bill insurance for services rendered, making private-pay or cash-based revenue the only option during this period. This is one of the most underestimated costs of building a de novo OT clinic and is a primary reason acquisition often generates faster returns.
The five highest-priority areas for OT clinic acquisition due diligence are: (1) payor mix analysis including reimbursement rate trends across Medicare, Medicaid, and commercial payers and denial rates by payer; (2) therapist licensure, credentialing files, and enforceability of non-compete and non-solicitation agreements; (3) revenue cycle quality including AR aging under 45 days, net collection rates, and open billing disputes; (4) referral source concentration and whether physician and school district relationships are documented and transferable; and (5) regulatory compliance history including HIPAA, Stark Law, state licensure, and any open Medicare audit or overpayment exposure.
Yes — many successful OT clinic acquisitions are completed by non-clinician buyers, including individual healthcare operators, PE-backed platforms, and physical therapy group practice owners. The key is ensuring the clinic has a credentialed, stable multi-therapist team that can operate independently of the owner, a professional revenue cycle management system, and referral relationships not personally dependent on the selling owner-therapist. Non-clinician buyers should budget for a strong clinical director or lead therapist retained post-close, and should prioritize deals where the seller is willing to transition over 6–12 months rather than exit immediately at closing.
The four deal-stopping red flags in OT clinic acquisitions are: (1) the owner-therapist personally generates more than 50% of clinical revenue with no documented succession plan or non-compete — patient attrition post-close can collapse acquired revenue; (2) Medicaid concentration above 50% of total revenue, which signals margin compression risk from state reimbursement rate cuts; (3) unresolved Medicare billing audits, credentialing lapses with major payers, or open overpayment demands that create post-close regulatory liability; and (4) three or more years of financial statements with heavy personal expense commingling and no clear, defensible EBITDA trail — this makes valuation and SBA financing both unreliable.
More Occupational Therapy Clinic Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers